Inhibition of α-glucosidase by aqueous extracts of some potent antidiabetic medicinal herbs

被引：130

作者：

Önal, S ^{[1
]}

Timur, S ^{[1
]}

Okutucu, B ^{[1
]}

Zihnioglu, F ^{[1
]}

机构：

[1] Ege Univ, Fac Sci, Dept Biochem, TR-35100 Izmir, Turkey

来源：

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY | 2005年 / 35卷 / 01期

关键词：

alpha-glucosidase inhibition; type 2 diabetes mellitus (NIDDM); Myrtus communis; Urtica dioica; Taraxacum officinale; Viscum album;

D O I：

10.1081/PB-200041438

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Diabetes mellitus is one of the most prevalant diseases of adults. Agents with alpha-glucosidase inhibitory activity have been useful as oral hypoglycemic drugs for the control of hyperglycemia in patients with type 2; noninsulin-dependent. diabetes mellitus (NIDDM). Investigation of some medicinal herbs: Urtica dioica, Taraxacum officinale, Viscum album, and Myrtus conununis with alpha-glucosidase inhibitor activity was conducted to identify a prophylactic effect for diabetes in vitro. All plants showed differing potent alpha-glucosidase inhibitory activity. However. Myrtus communis strongly inhibited the enzyme (IC50 = 38 mug/mL). The inhibitory effect of these plants and some common antidiabetic drugs against the enzyme source (baker's yeast, rabbit liver, and small intestine) were also searched. Approximately all inhibitors used in this study showed quite different inhibitory activities, according to alpha-glucosidase origins. Furthermore, subsequent separation of the active material from Myrtus communis by HPLC showed that only one fraction acted as an alpha-glucosidase inhibitor.

引用

页码：29 / 36

页数：8

共 23 条

[1]

BISCHOFF H, 1995, CLIN INVEST MED, V18, P303

[2]

BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3

[3] A rational approach to drug therapy of type 2 diabetes mellitus [J].

Chehade, JM ;

Mooradian, AD .

DRUGS, 2000, 60 (01) :95-113

[4] Molecular mechanism in alpha-glucosidase and glucoamylase [J].

Chiba, S .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1997, 61 (08) :1233-1239

[5]

CONIFF RF, 1996, DIABETES S2, V45, pA221

[6] The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin [J].

Fuder, H ;

Kleist, P ;

Birkel, M ;

Ehrlich, A ;

Emeklibas, S ;

Maslak, W ;

Stridde, E ;

Wetzelsberger, N ;

Wieckhorst, G ;

Lucker, PW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (02) :153-157

[7] Efficacy and safety of Touchi Extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus [J].

Hiroyuki, F ;

Tomohide, Y ;

Kazunori, O .

JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2001, 12 (06) :351-356

[8] Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients [J].

Johnston, PS ;

Lebovitz, HE ;

Coniff, RF ;

Simonson, DC ;

Raskin, P ;

Munera, CL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1515-1522

[9]

KAMADA Y, 1984, J ANTIBIOT, V87, P1301

[10]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

← 1 2 3 →